首页|炎症指标对局部晚期非小细胞肺癌患者根治性放疗致放射性肺炎的预测意义

炎症指标对局部晚期非小细胞肺癌患者根治性放疗致放射性肺炎的预测意义

扫码查看
目的 评价单核细胞与淋巴细胞比值(MLR)和其他血液生物标志物预测局部晚期非小细胞肺癌(LA-NSCLC)患者放疗后发生放射性肺炎的临床意义.方法 回顾性收集 2019 年 4 月至 2023 年 4 月期间接受放化疗的 106 例LA-NSCLC患者.根据放疗后是否发生放射性肺炎分为放射性肺炎组和对照组.分析两组患者人口统计学特征、临床数据、实验室检查结果和治疗参数.多因素Logistic回归分析影响发生放射性肺炎的因素.Kaplan-Meier法绘制生存曲线,生存差异行Log-rank检验.结果 61 例患者发生放射性肺炎.发生放射性肺炎患者 1、2、3 年生存率低于对照组(P=0.017).放射性肺炎组ECOG PS 1~2 分患者比例、PTV、双肺V5 和V20 也高于对照组(P<0.05).与对照组比较,放射性肺炎组患者放疗前淋巴细胞计数绝对值略低(P=0.019),CRP水平(P=0.037)和MLR(P<0.001)较高.多因素Logistic模型分析显示,ECOG评分(P=0.043)、双肺V20(P=0.021)、CRP(P=0.008)和MLR(P=0.007)是影响发生放射性肺炎的因素.MLR<0.51 组患者的中位总生存期(OS)未达,明显长于MLR≥0.51 组患者的 32.2 个月(范围 7.7~44.5 个月),差异有统计学意义(P=0.004).结论 MLR是预测Ⅲ期LA-NSCLC患者放化疗后发生放射性肺炎的生物标志物.
Significance of inflammation index in predicting radiation pneumonia induced by radical radiotherapy in patients with locally advanced non-small cell lung cancer
Objective To evaluate the significance of monocyte to lymphocyte ratio(MLR)and other blood biomarkers in predicting radiation pneumonia after radiotherapy in patients with locally advanced non-small cell lung cancer(LA-NSCLC).Methods One hundred and six patients with LA-NSCLC who received chemoradiotherapy between April 2019 and April 2023 were collected.Radiation pneumonia group and control group were divided according to whether radiation pneumonia occurred after radiotherapy.Patient demographic characteristics,clinical data,laboratory findings,and treatment parameters were analyzed.Multivariate Logistic regression analysis of the factors affecting the occurrence of radiation pneumonia.Survival curve was drawn by Kaplan-Meier method,and survival difference was tested by Log-rank.Results Radiation pneumonia occurred in 61 patients.The 1-,2-and 3-year survival rates of patients with radiation pneumonia were much lower than those of control group(P=0.017).The proportion of patients with ECOG PS 1-2 score,PTV,V5 and V20 in the radiation pneumonia group were also higher than those in the control group(P<0.05).Compared with the control group,the absolute lymphocyte count before radiotherapy was slightly lower in the radiation pneumonia group(P=0.019),and the CRP level(P=0.037)and MLR(P<0.001)were higher.Multivariate Logistic model analysis showed that ECOG score(P=0.043),double lung V20(P=0.021),CRP(P=0.008)and MLR(P=0.007)were the factors affecting radiation pneumonia.The median OS in the MLR<0.51 group was lower than that in the MLR≥0.51 group at 32.2 months(ranging from 7.7 to 44.5 months),the difference was statistically significant(P=0.004).Conclusion MLR is a biomarker for predicting radiation pneumonia in patients with stage Ⅲ LA-NSCLC after chemoradiotherapy.

Locally advanced non-small cell lung cancer(LA-NSCLC)Monocyte to lymphocyte ratio(MLR)Radiation pneumoniaPrognosis

张亮、高振、宣婷婷

展开 >

226000 江苏南通 南通市第一人民医院放疗科

局部晚期非小细胞肺癌 单核细胞与淋巴细胞比值 放射性肺炎 预后

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(11)